A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis-Reference-Cited by-同舟云学术

A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis

Published:2018-09 Issue:3 Volume:8 Page:224-234
ISSN:0973-6883
Container-title:Journal of Clinical and Experimental Hepatology
language:en
Short-container-title:Journal of Clinical and Experimental Hepatology

Author:

Mehta Gautam^ORCID,Rousell Sam,Burgess Gary,Morris Mark,Wright Gavin,McPherson Stuart,Frenette Catherine,Cave Matthew,Hagerty David T.,Spada Alfred,Jalan Rajiv

Publisher

Elsevier BV

Subject

Hepatology

Reference30 articles.

1. Acute-on-chronic liver failure: pathophysiological basis of therapeutic options;Jalan;Blood Purif,2002

2. Acute-on chronic liver failure;Jalan;J Hepatol,2012

3. The impact of organ dysfunction in cirrhosis: survival at a cost?;Shawcross;J Hepatol,2012

4. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis;Moreau;Gastroenterology,2013

5. Study E-CCC. Acute-on-chronic liver failure: a new syndrome that will re-classify cirrhosis;Arroyo;J Hepatol,2015

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Therapeutic Approaches in Treatment of Acute-on-Chronic Liver Failure;Seminars in Liver Disease;2023-11

2. New Insights of Early Brain Injury after Subarachnoid Hemorrhage: A Focus on the Caspase Family;Current Neuropharmacology;2023-02

3. Mechanisms of Recovery from and Strategies for Survival of Severe Alcoholic Hepatitis and ACLF;Alcohol and Alcohol-related Diseases;2023

4. Caspase-2 in liver disease and hepatocellular carcinoma;Exploration of Digestive Diseases;2022-10-31

5. Investigational drugs in early clinical development for portal hypertension;Expert Opinion on Investigational Drugs;2022-07-05